This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Celanese (CE) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Celanese (CE) Surpasses Earnings and Sales Estimates in Q2
by Zacks Equity Research
Celanese's (CE) Q2 results benefit from increase in pricing and volumes.
Vale (VALE) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Vale's (VALE) first-quarter results are likely to reflect higher iron ore production and escalating iron ore prices.
Celanese (CE) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of 11.80% and 15.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Bunge Limited's (BG) Q2 Earnings?
by Zacks Equity Research
Bunge Limited's (BG) second-quarter results are likely to reflect favorable markets in the agribusiness and Refined and Specialty Oils segments.
National Steel (SID) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
National Steel's (SID) Q2 results are likely to reflect solid demand for steel, aided by strong recovery in the automotive and construction markets.
Sherwin-Williams (SHW) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Sherwin-Williams' (SHW) second-quarter performance is likely to reflect strong demand and cost-control initiatives.
Southern Copper (SCCO) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Southern Copper's (SCCO) second-quarter 2021 results are likely to reflect higher metal prices.
Should You Buy Celanese (CE) Ahead of Earnings?
by Zacks Equity Research
Celanese (CE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Higher Copper Prices Drive Freeport's (FCX) Q2 Earnings?
by Zacks Equity Research
Freeport's (FCX) profitability is expected to have boosted by higher average realized price for copper in Q2.
Will Higher Sales Prices Aid Nucor's (NUE) Q2 Earnings?
by Zacks Equity Research
Profitability across Nucor's (NUE) steel mills and steel products segments is expected to have boosted by higher average sales prices in Q2.
Celanese (CE) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Celanese's (CE) Q2 performance is likely to have benefited from productivity actions, investments in high-return organic projects and strategic acquisitions.
Earnings Growth & Price Strength Make Celanese (CE) a Stock to Watch
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Celanese (CE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese (CE) Authorizes Share Buyback Worth $1 Billion
by Zacks Equity Research
Celanese's (CE) new share repurchase authorization reflects roughly 6% of the company's shares outstanding.
CE vs. LTHM: Which Stock Is the Better Value Option?
by Zacks Equity Research
CE vs. LTHM: Which Stock Is the Better Value Option?
Celanese (CE) to Buy Exxon Mobil's Santoprene Business for $1.15B
by Zacks Equity Research
Celanese's (CE) acquisition of Santoprene TPV elastomers business of Exxon Mobil will broaden its portfolio of engineered solutions.
ExxonMobil (XOM) Divests Santoprene to Celanese for $1.15B
by Zacks Equity Research
ExxonMobil's (XOM) global Santoprene business divestment includes two manufacturing sites located in Pensacola, FL and Newport in Wales.
Here's Why You Should Add Celanese (CE) to Your Portfolio
by Zacks Equity Research
Celanese (CE) benefits from its productivity actions, investments in high-return projects, demand recovery and strategic acquisitions.
U.S. Specialty Chemical Rebound Continues as May Volume Rises
by Anindya Barman
U.S. specialty chemical volumes ticked up 0.7% in May as the industry continues its recovery after being hit by the winter storm in the U.S. Gulf Coast earlier this year.
Celanese (CE) Acquires Azoty's POM Technology, Drives Volume Gain
by Zacks Equity Research
Celanese (CE) takes over the POM production technology from Grupa Azoty and the transaction will lead to volume increment and catalyze the growth in its business unit.
CE vs. LTHM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CE vs. LTHM: Which Stock Is the Better Value Option?
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
by Zacks Equity Research
Celanese (CE) gains from its productivity actions, investments in high-return organic projects and strategic acquisitions.
Why This 1 Basic Materials Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Ingevity (NGVT) Announces Price Hike of Chemical-Based Products
by Zacks Equity Research
Ingevity's (NGVT) price hike is due to continued strong market demand as well as rising raw materials and logistics costs.